WELLS FARGO & COMPANY/MN
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in MRVI
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$118,268
-$281,592 QoQ
Shares Held
41,791
-66.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,293,431,965 across 386 Biotechnology names. MRVI ranks #213 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in MRVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $118,268 | 41,791 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $399,860 | 123,034 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $241,914 | 84,291 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $190,960 | 79,237 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $119,005 | 53,849 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $287,132 | 52,685 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $313,152 | 37,684 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $282,604 | 39,470 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $71,907 | 8,294 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $62,244 | 9,503 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $300,380 | 30,038 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $376,105 | 30,258 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $456,247 | 32,566 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $463,327 | 32,378 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $726,404 | 28,453 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $801,728 | 28,220 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,199,083 | 62,350 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,451,873 | 106,250 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,038,948 | 326,792 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,839,450 | 92,007 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,467,770 | 97,300 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,879,938 | 67,021 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||